{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T03:04:04Z","timestamp":1783825444894,"version":"3.55.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-025-02340-3","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T17:45:51Z","timestamp":1753983951000},"page":"2229-2237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of antithrombotics in patients with atrial fibrillation undergoing hemodialysis: a nationwide cohort study in Korea"],"prefix":"10.1093","volume":"38","author":[{"given":"Se-Jun","family":"PARK","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong Kil","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhyeon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Jin","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3516-2822","authenticated-orcid":false,"given":"Jeonggyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"4","key":"2340_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40261-021-01016-7","volume":"41","author":"HY Chen","year":"2021","unstructured":"Chen HY, Ou SH, Huang CW, Lee PT, Chou KJ, Lin PC et al (2021) Efficacy and safety of direct oral anticoagulants vs warfarin in patients with chronic kidney disease and dialysis patients: a systematic review and meta-analysis. Clin Drug Investig 41(4):341\u2013351","journal-title":"Clin Drug Investig"},{"issue":"23","key":"2340_CR2","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","volume":"130","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC et al (2014) 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American college of cardiology\/American heart association task force on practice guidelines and the heart rhythm society. Circulation 130(23):2071\u20132104","journal-title":"Circulation"},{"issue":"9921","key":"2340_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921):955\u2013962","journal-title":"Lancet"},{"issue":"04","key":"2340_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0040-1718729","volume":"121","author":"HK Kim","year":"2021","unstructured":"Kim HK, Tantry US, Smith SC, Jeong MH, Park SJ, Kim MH et al (2021) The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost 121(04):422\u2013432","journal-title":"Thromb Haemost"},{"issue":"2","key":"2340_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4070\/kcj.2019.0099","volume":"50","author":"KH Lee","year":"2020","unstructured":"Lee KH, Cho JG, Lee N, Cho KH, Jeong HK, Park H et al (2020) Impact of anticoagulation intensity in korean patients with atrial fibrillation: is it different from western population? Korean Circ J 50(2):163\u2013175","journal-title":"Korean Circ J"},{"issue":"3","key":"2340_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.chest.2019.04.108","volume":"156","author":"YH Chan","year":"2019","unstructured":"Chan YH, Lee HF, See LC, Tu HT, Chao TF, Yeh YH et al (2019) Effectiveness and safety of four direct oral anticoagulants in Asian patients with nonvalvular atrial fibrillation. Chest 156(3):529\u2013543","journal-title":"Chest"},{"issue":"24","key":"2340_CR7","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/eurheartj\/ehy060","volume":"39","author":"MP Turakhia","year":"2018","unstructured":"Turakhia MP, Blankestijn PJ, Carrero JJ, Clase CM, Deo R, Herzog CA et al (2018) Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Eur Heart J 39(24):2314\u20132325","journal-title":"Eur Heart J"},{"issue":"3","key":"2340_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/M19-0087","volume":"171","author":"JT Ha","year":"2019","unstructured":"Ha JT, Neuen BL, Cheng LP, Jun M, Toyama T, Gallagher MP et al (2019) Benefits and harms of oral anticoagulant therapy in chronic kidney disease. Ann Intern Med 171(3):181","journal-title":"Ann Intern Med"},{"issue":"3","key":"2340_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.23876\/j.krcp.19.015","volume":"38","author":"HS Lee","year":"2019","unstructured":"Lee HS, Song YR, Kim JK, Joo N, Kim C, Kim HJ et al (2019) Outcomes of vascular access in hemodialysis patients: analysis based on the Korean national health insurance database from 2008 to 2016. Kidney Research and Clinical Practice 38(3):391\u2013398","journal-title":"Kidney Research and Clinical Practice"},{"issue":"10","key":"2340_CR10","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1161\/STROKEAHA.116.013880","volume":"47","author":"TF Chao","year":"2016","unstructured":"Chao TF, Lip GYH, Liu CJ, Tuan TC, Chen SJ, Wang KL et al (2016) Validation of a modified CHA 2 DS 2 -VASc score for stroke risk stratification in Asian patients with atrial fibrillation. Stroke 47(10):2462\u20132469","journal-title":"Stroke"},{"key":"2340_CR11","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS). Euro Heart J, ehae176"},{"issue":"1","key":"2340_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","volume":"83","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM et al (2024) 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation. J Am Coll Cardiol 83(1):109\u2013279","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2340_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12882-016-0368-6","volume":"17","author":"J Tan","year":"2016","unstructured":"Tan J, Liu S, Segal JB, Alexander GC, McAdams-DeMarco M (2016) Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis. BMC Nephrol 17(1):157","journal-title":"BMC Nephrol"},{"issue":"5","key":"2340_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s10557-020-07108-4","volume":"35","author":"LC See","year":"2021","unstructured":"See LC, Lee HF, Chao TF, Li PR, Liu JR, Wu LS et al (2021) Effectiveness and safety of direct oral anticoagulants in an asian population with atrial fibrillation undergoing dialysis: a population-based cohort study and meta-analysis. Cardiovasc Drugs Ther 35(5):975\u2013986","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"2340_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/eurheartj\/ehx730","volume":"39","author":"FWA Verheugt","year":"2018","unstructured":"Verheugt FWA, Gao H, Al Mahmeed W, Ambrosio G, Angchaisuksiri P, Atar D et al (2018) Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry. Eur Heart J 39(6):464\u2013473","journal-title":"Eur Heart J"},{"issue":"11","key":"2340_CR16","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1093\/ndt\/gfab060","volume":"37","author":"AS De Vriese","year":"2022","unstructured":"De Vriese AS, Heine G (2022) Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion. Nephrol Dial Transplant 37(11):2072\u20132079","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2340_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","volume":"47","author":"H Kamel","year":"2016","unstructured":"Kamel H, Okin PM, Elkind MSV, Iadecola C (2016) Atrial fibrillation and mechanisms of stroke. Stroke 47(3):895\u2013900","journal-title":"Stroke"},{"issue":"10","key":"2340_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrcardio.2014.104","volume":"11","author":"GN Levine","year":"2014","unstructured":"Levine GN, Jeong YH, Goto S, Anderson JL, Huo Y, Mega JL et al (2014) World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol 11(10):597\u2013606","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"2340_CR19","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1161\/STROKEAHA.117.017114","volume":"48","author":"CY Yoon","year":"2017","unstructured":"Yoon CY, Noh J, Jhee JH, Chang TI, Kang EW, Kee YK et al (2017) Warfarin use in patients with atrial fibrillation undergoing hemodialysis: a nationwide population-based study. Stroke 48(9):2472\u20132479","journal-title":"Stroke"},{"issue":"2","key":"2340_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1253\/circj.CJ-21-0682","volume":"86","author":"Y Koretsune","year":"2022","unstructured":"Koretsune Y, Hoshino H, Matsuo Y, Ibuki T, Morimoto T (2022) Comparative safety and effectiveness of apixaban vs. warfarin in oral anticoagulant-na\u00efve japanese patients with non-valvular atrial fibrillation\u2014a retrospective chart review Study. Circ J 86(2):213\u2013221","journal-title":"Circ J"},{"issue":"1","key":"2340_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3349\/ymj.2022.0455","volume":"64","author":"H Park","year":"2023","unstructured":"Park H, Yu HT, Kim TH, Park J, Park JK, Kang KW et al (2023) Oral anticoagulation therapy in atrial fibrillation patients with advanced chronic kidney disease: CODE-AF registry. Yonsei Med J 64(1):18","journal-title":"Yonsei Med J"},{"issue":"9","key":"2340_CR22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.amjmed.2015.03.034","volume":"128","author":"G Renda","year":"2015","unstructured":"Renda G, Di Nicola M, De Caterina R (2015) Net clinical benefit of non-vitamin k antagonist oral anticoagulants versus warfarin in phase III atrial fibrillation trials. Am J Med 128(9):1007-1014.e2","journal-title":"Am J Med"},{"issue":"1","key":"2340_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/jcm9010123","volume":"9","author":"M van Zyl","year":"2020","unstructured":"van Zyl M, Abdullah HM, Noseworthy PA, Siontis KC (2020) Stroke prophylaxis in patients with atrial fibrillation and end-stage renal disease. J Clin Med 9(1):123","journal-title":"J Clin Med"},{"issue":"2","key":"2340_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ki.2011.44","volume":"80","author":"SV Brodsky","year":"2011","unstructured":"Brodsky SV, Nadasdy T, Rovin BH, Satoskar AA, Nadasdy GM, Wu HM et al (2011) Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 80(2):181\u2013189","journal-title":"Kidney Int"},{"issue":"Supplement_1","key":"2340_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/eurheartjsupp\/suae087","volume":"27","author":"R De Caterina","year":"2025","unstructured":"De Caterina R, Chiusolo S (2025) Over 10\u00a0years of non-vitamin K antagonist oral anticoagulants: highlights, challenges, and future developments. Euro Heart J Suppl. 27(Supplement_1):6\u201311","journal-title":"Euro Heart J Suppl."},{"issue":"7","key":"2340_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.113.002927","volume":"128","author":"BA Steinberg","year":"2013","unstructured":"Steinberg BA, Kim S, Piccini JP, Fonarow GC, Lopes RD, Thomas L et al (2013) Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation. Circulation 128(7):721\u2013728","journal-title":"Circulation"},{"issue":"8","key":"2340_CR27","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s40620-022-01413-x","volume":"35","author":"K Parker","year":"2022","unstructured":"Parker K, Hartemink J, Saha A, Mitra R, Lewis P, Power A et al (2022) A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease. J Nephrol 35(8):2015\u20132033","journal-title":"J Nephrol"},{"issue":"1","key":"2340_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/jcm10010083","volume":"10","author":"M Magnocavallo","year":"2020","unstructured":"Magnocavallo M, Bellasi A, Mariani MV, Fusaro M, Ravera M, Paoletti E et al (2020) Thromboembolic and bleeding risk in atrial fibrillation patients with chronic kidney disease: role of anticoagulation therapy. JCM 10(1):83","journal-title":"JCM"},{"issue":"9","key":"2340_CR29","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","volume":"137","author":"KA Hicks","year":"2018","unstructured":"Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B et al (2018) 2017 cardiovascular and stroke endpoint definitions for clinical trials. Circulation 137(9):961\u2013972","journal-title":"Circulation"},{"issue":"1","key":"2340_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-STS313","volume":"25","author":"EA Stuart","year":"2010","unstructured":"Stuart EA (2010) Matching methods for causal inference: a review and a look forward. Stat Sci 25(1):1\u201321","journal-title":"Stat Sci"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02340-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02340-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02340-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:22Z","timestamp":1777564762000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/8\/2229\/8457475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["2340"],"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02340-3","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Institutional Review Board of the Kangbuk Samsung Hospital (KBSMC 2022-04-018), which waived the requirement for informed consent because of the retrospective nature of the study. No animal research was conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study protocol was approved by the Institutional Review Board of the Kangbuk Samsung Hospital (KBSMC 2022-04-018).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"The requirement for informed consent was waived due to the retrospective nature of the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}